Healthcare >> Analyst Interviews >> June 15, 2000

Biotechnology Stocks : Mark Augustine – U.s. Bancorp Piper Jaffray

MARK AUGUSTINE is a Senior Research Analyst with U.S. Bancorp Piper Jaffray's Equity Research Group, where he focuses on biotechnology companies. He was most recently a Biotechnology Analyst and a Vice President in the Equity Research Department at SG Cowen Securities. He previously worked at Morgan Stanley & Co. and Canaan Partners, a venture capital firm. Mr. Augustine graduated Magna Cum Laude from Yale College and received his MBA from Harvard University. Profile
TWST: Mark, let's start with the approach that you take to biotechnology

at U.S. Bancorp Piper Jaffray.

Mr. Augustine: Our biotechnology group is comprised of three senior